UY28596A1 - Nuevo anhidrato cristalino con accion anticolinergica - Google Patents

Nuevo anhidrato cristalino con accion anticolinergica

Info

Publication number
UY28596A1
UY28596A1 UY28596A UY28596A UY28596A1 UY 28596 A1 UY28596 A1 UY 28596A1 UY 28596 A UY28596 A UY 28596A UY 28596 A UY28596 A UY 28596A UY 28596 A1 UY28596 A1 UY 28596A1
Authority
UY
Uruguay
Prior art keywords
anticolinergic
action
new crystal
anhydrate
pulmonary disease
Prior art date
Application number
UY28596A
Other languages
English (en)
Inventor
Dr Peter Sieger
Dr Waldemar Pfrengle
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34530662&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY28596(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of UY28596A1 publication Critical patent/UY28596A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se refiere a un nuevo anhidrato cristalino de bromuro de tiotropio, a procedimientos para su obtención, y a su empleo para preparar un medicamento para tratar enfermedades de las vías respiratorias, en especial para tratar la enfermedad pulmonar obstructiva crónica (siglas inglesas COPD= chronic obstructive pulmonary disease) y el asma.
UY28596A 2003-11-03 2004-11-03 Nuevo anhidrato cristalino con accion anticolinergica UY28596A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03025077 2003-11-03

Publications (1)

Publication Number Publication Date
UY28596A1 true UY28596A1 (es) 2005-06-30

Family

ID=34530662

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28596A UY28596A1 (es) 2003-11-03 2004-11-03 Nuevo anhidrato cristalino con accion anticolinergica

Country Status (34)

Country Link
EP (1) EP1682542B1 (es)
JP (1) JP4553902B2 (es)
KR (2) KR101285571B1 (es)
CN (1) CN100509809C (es)
AR (1) AR046319A1 (es)
AT (1) ATE453641T1 (es)
AU (1) AU2004285684B2 (es)
BR (1) BRPI0415636A (es)
CA (1) CA2544352C (es)
CO (1) CO5690641A2 (es)
CY (1) CY1110339T1 (es)
DE (1) DE502004010602D1 (es)
DK (1) DK1682542T3 (es)
EA (1) EA008587B1 (es)
EC (1) ECSP066543A (es)
ES (1) ES2338563T3 (es)
HK (1) HK1099752A1 (es)
HR (1) HRP20100029T1 (es)
IL (1) IL175126A (es)
ME (1) ME00349B (es)
MX (1) MX272045B (es)
MY (1) MY146628A (es)
NO (1) NO20062569L (es)
NZ (1) NZ547581A (es)
PE (1) PE20050996A1 (es)
PL (1) PL1682542T3 (es)
PT (1) PT1682542E (es)
RS (2) RS51599B (es)
SI (1) SI1682542T1 (es)
TW (1) TWI336330B (es)
UA (1) UA82909C2 (es)
UY (1) UY28596A1 (es)
WO (1) WO2005042527A1 (es)
ZA (1) ZA200602344B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2606552A1 (en) * 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Crystalline forms of tiotropium bromide
PT1869035E (pt) * 2005-12-19 2013-01-10 Sicor Inc Novas formas de brometo de tiotrópio e processos para sua preparação
US9108962B2 (en) 2005-12-19 2015-08-18 Sicor, Inc. Forms of tiotropium bromide and processes for preparation thereof
RU2453547C2 (ru) * 2005-12-19 2012-06-20 Сикор Инк. Новые формы тиотропия бромида и способы их получения
CN101355937A (zh) * 2006-01-04 2009-01-28 贝林格尔·英格海姆国际有限公司 噻托铵盐在治疗中度持续性哮喘中的用途
CN100999521B (zh) * 2006-01-13 2010-12-08 江苏正大天晴药业股份有限公司 结晶性抗胆碱药噻托溴铵
US20080051582A1 (en) 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide
CN101032484B (zh) * 2007-04-02 2010-05-26 南京卡文迪许生物工程技术有限公司 一种噻托溴铵胶囊型吸入粉雾剂
GB0716026D0 (en) 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
EP2362766A2 (en) * 2008-11-04 2011-09-07 Cipla Limited Pharmaceutical aerosol composition
JP5650120B2 (ja) * 2008-11-04 2015-01-07 シプラ・リミテッド 低い結晶化度を有する臭化チオトロピウム
CA2768553C (en) 2009-08-07 2016-08-02 Generics [Uk] Limited Anhydrate of tiotropium bromide
TR201111589A2 (tr) * 2011-03-03 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür susuz kristal formu.
CZ304368B6 (cs) 2011-11-28 2014-04-02 Zentiva, K.S. Směsný solvát tiotropium bromidu a způsob jeho přípravy
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
WO2014042605A1 (en) * 2012-09-11 2014-03-20 Mahmut Bilgic New tiotropium bromide crystalline form
MX2015005319A (es) 2012-11-05 2015-07-14 Zentiva K S Estabilizacion de solvatos de tiotropio.
EP2913332A1 (en) 2014-02-27 2015-09-02 Euticals S.P.A. Crystalline form of tiotropium bromide with lactose
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
EP3414243A1 (en) 2016-02-11 2018-12-19 Sima Patent Ve Lisanslama Hizmetleri Ltd. STI Crystalline form of tiotropium bromide anhydrate
EP4108230A1 (en) 2021-06-24 2022-12-28 Laboratoires SMB New dry powder composition of tiotropium for inhalation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
CA2425539C (en) * 2000-10-12 2007-04-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline monohydrate, processes for the preparation thereof and the use thereof for preparing a pharmaceutical composition
DE10111843A1 (de) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von inflammatorischen Erkrankungen
PL208137B1 (pl) * 2001-06-22 2011-03-31 Boehringer Ingelheim Pharma Bezwodny krystaliczny bromek tiotropium, sposób jego wytwarzania i zastosowanie krystalicznego monohydratu bromku tiotropium do wytwarzania krystalicznego bezwodnego bromku tiotropium

Also Published As

Publication number Publication date
KR101313904B1 (ko) 2013-09-30
EP1682542B1 (de) 2009-12-30
CA2544352A1 (en) 2005-05-12
AR046319A1 (es) 2005-11-30
KR20060121131A (ko) 2006-11-28
CN1875019A (zh) 2006-12-06
EA200600853A1 (ru) 2006-10-27
MEP51708A (en) 2011-02-10
RS51599B (en) 2011-08-31
TW200526652A (en) 2005-08-16
CO5690641A2 (es) 2006-10-31
DK1682542T3 (da) 2010-05-10
CY1110339T1 (el) 2015-01-14
HK1099752A1 (en) 2007-08-24
NZ547581A (en) 2009-03-31
MXPA06004940A (es) 2006-07-20
TWI336330B (en) 2011-01-21
IL175126A0 (en) 2006-09-05
EP1682542A1 (de) 2006-07-26
ECSP066543A (es) 2006-10-17
WO2005042527A1 (de) 2005-05-12
RS20060291A (en) 2008-06-05
CN100509809C (zh) 2009-07-08
CA2544352C (en) 2013-07-16
ME00349B (me) 2011-05-10
PE20050996A1 (es) 2005-12-20
KR101285571B1 (ko) 2013-07-15
MY146628A (en) 2012-09-14
BRPI0415636A (pt) 2006-12-12
JP4553902B2 (ja) 2010-09-29
KR20120036381A (ko) 2012-04-17
EA008587B1 (ru) 2007-06-29
ATE453641T1 (de) 2010-01-15
ES2338563T3 (es) 2010-05-10
NO20062569L (no) 2006-07-12
DE502004010602D1 (de) 2010-02-11
PL1682542T3 (pl) 2010-06-30
AU2004285684A1 (en) 2005-05-12
HRP20100029T1 (hr) 2010-02-28
SI1682542T1 (sl) 2010-04-30
JP2007509894A (ja) 2007-04-19
UA82909C2 (en) 2008-05-26
AU2004285684B2 (en) 2011-07-14
IL175126A (en) 2010-11-30
ZA200602344B (en) 2007-07-25
PT1682542E (pt) 2010-01-27
MX272045B (en) 2009-11-23

Similar Documents

Publication Publication Date Title
ECSP066543A (es) Nuevo anhidrato cristalino con accion anticolinergica
UY29506A1 (es) Nuevas formas cristalinas de bromuro de tiotropio
DK1718336T3 (da) Ny kombination af anticholinergikum og beta-mimetika til behandling af luftvejssygdomme
WO2006117300A3 (en) Crystalline forms of tiotropium bromide
DE602006004963D1 (de) Kombination von methylxanthinverbindungen und steroiden zur behandlung chronischer atemwegserkrankungen
EP1737499A4 (en) TREATMENT OF CHRONIC OBSTRUCTIVE LUNG DISEASE BY INHALATION OF LOW DOSES OF A PROTEASE HEMMER
AR047386A1 (es) Uso de pteridinas sustituidas para el tratamiento de enfermedades de las vias respiratorias
CL2008001593A1 (es) Compuestos derivados de heterociclos, antagonistas para el ccr2; y uso de los compuestos para tratar afecciones o enfermedades del tracto respiratorio, como enfermedad pulmonar obstructiva cronica y asma.
ECSP024268A (es) Nuevos polvos para inhalacion que contienen tiotropio
CR9832A (es) Compuestos de pirimidina amida como inhibidores de pgds
CR11472A (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
EA201190108A1 (ru) Фармацевтическая композиция для ингаляции
UY31687A1 (es) Nueva dosificacion y formulacion
ATE496913T1 (de) Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen
ECSP088287A (es) Una combinación de compuestos que puede ser utilizada en el tratamiento de enfermedades respiratorias, especialmente enfermedad pulmonar obstructiva crónica (epoc) y asma
UY28589A1 (es) Nuevas sales de tiotropio, procedimientos para su preparación , así como formulaciones medicamentosas que las contienen
CL2009000250A1 (es) Compuestos derivados de pirazolo[3,4-b]piridina carboxamida; composicion farmaceutica que los comprende; y su uso en el tratamiento del asma, epoc y rinitis.
EA201200855A1 (ru) Модуляторы crth2
IL189182A0 (en) A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma
UY28096A1 (es) Nueva formulación pulveurlenta que contiene tiotropio destinada a la inhalación
HN2003000099A (es) Aroilpiridinonas monociclicas
ZA200801408B (en) A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (COPD) and asthma
ZA200801407B (en) A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (COPD) and asthma
UA107820C2 (en) Antagonists receptor ccr2 and their use

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20161110